Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Plos One|October 3, 2013
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivoZoë L S Brookes, Emily N Stedman, Nicola J Brown, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studiesRaffaella Bigoni, Daniela Rizzi, Anna Rizzi, et al.
Ultrasound (Leeds, England)|May 1, 2019
A preclinical ultrasound method for the assessment of vascular disease progression in murine modelsJustyna Janus, Baris Kanber, Wadhah Mahbuba, et al.
Peptides|September 12, 2006
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studiesRaffaella Vergura, Elena Valenti, Christopher P Hebbes, et al.
Bioorganic & Medicinal Chemistry|May 11, 2007
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acidsMarika Arduin, Barbara Spagnolo, Girolamo Calò, et al.
British Journal of Pharmacology|May 16, 2002
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptorGirolamo Calo, Anna Rizzi, Daniela Rizzi, et al.
Pageof 11